An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Clinical trial NCT00229658 · COMPLETED

Trial details

NCT number: NCT00229658
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus

Start date: 2005-09-01
Primary completion: 2008-05-01
Enrollment: 1297

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.